From my lay reading this is suggesting that HER is involved in arthritis.
This would maybe suggest a common link, which I suppose might be expected given the often suggested link between COX 2 arthritis and BC, joint pains as a result of BC treatments etc.
Interesting.
RB
http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum
ABSTRACT
1: Am J Physiol Cell Physiol. 2005 Jul;289(1):C82-8. Epub 2005 Mar 2. Related Articles, Links
Click here to read
Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells.
Kitamura T, Sekimata M, Kikuchi S, Homma Y.
Department of Biomolecular Science and Orthopedics, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
Hyperplasia of synovial lining cells is one of the main features of rheumatoid arthritis (RA). We previously reported that ERBB2 is highly expressed in RA synovial cells and that it plays an important role in their hyperproliferative growth. Recent findings have suggested that poly(ADP-ribose) polymerase-1 (PARP-1) is involved in the transactivation of NF-kappaB-dependent genes such as ERBB2. In the present study, we investigated the role of PARP-1 in ERBB2 transcription in RA synovial cells. The expression level of PARP-1 was significantly high in synovial cells derived from three patients with RA, compared with three patients with osteoarthritis (OA). Luciferase assays revealed that PARP-1 augments the transcription of the ERBB2 gene and that a region between -404 and -368 is responsible for this activation. A protein with an apparent molecular mass of 115 kDa was isolated mainly from nuclear extracts of RA synovial cells with an affinity matrix harboring a DNA fragment identical to the above region. Mass spectrometric analysis demonstrated this protein to be PARP-1. Southwestern blot analysis showed that PARP-1 binds to this region, but not to adjacent regions. PARP-1 associates directly with NF-kappaB, and a chromatin immunoprecipitation assay indicated that these proteins interact with this enhancer region in the ERBB2 gene. Treatment of RA synovial cells with PARP-1 small interfering RNA attenuated their ERBB2 expression, while an inhibitor of the polymerase activity of PARP-1 had no effect. PARP-1 DNA binding is not required for transcriptional activation. These findings suggest that PARP-1 is involved in the expression of ERBB2 in concert with NF-kappaB, which might be associated with the proliferation of RA synovial cells.
PMID: 15743888 [PubMed - indexed for MEDLINE]
Threaded Mode